Article Information
History
- March 12, 2021.
Article Versions
- You are currently viewing Version 1 of this article (March 12, 2021 - 14:30).
- View Version 2, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- David R. Martinez1,*,
- Alexandra Schaefer1,
- Sarah R. Leist1,
- Gabriela De la Cruz2,
- Ande West1,
- Elena N. Atochina-Vasserman4,
- Robert Parks5,
- Maggie Barr5,
- Dapeng Li5,
- Boyd Yount1,
- Kevin O. Saunders5,
- Drew Weissman4,
- Barton F. Haynes5,
- Stephanie A. Montgomery3 and
- Ralph S. Baric1,*
- 1Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA
- 2Lineberger Comprehensive Cancer Center, University of North Carolina School of Medicine, Chapel Hill, NC, USA
- 3Department of Laboratory Medicine and Pathology, University of North Carolina School of Medicine, Chapel Hill, NC, USA
- 4Infectious Disease Division, Department of Medicine, Perelman School of Medicine, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA
- 5Duke Human Vaccine Institute, Duke University School of Medicine, Durham, NC, USA
- ↵*Corresponding authors. David R. Martinez, D.R.M., david.rafael.martinez{at}gmail.com, Ralph S. Baric, R.S.B., rbaric{at}email.unc.edu